Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-31

FDA Approved: CALQUENCE — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved CALQUENCE (acalabrutinib) from the original application by AstraZeneca Pharmaceuticals LP. This marks the initial approval of acalabrutinib for man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CALQUENCE (ACALABRUTINIB)

Snippet

ORIG AP for CALQUENCE (ACALABRUTINIB)